A detailed history of Everpar Advisors LLC transactions in Natera, Inc. stock. As of the latest transaction made, Everpar Advisors LLC holds 1,774 shares of NTRA stock, worth $239,702. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,774
Previous 2,064 14.05%
Holding current value
$239,702
Previous $224 Million 0.76%
% of portfolio
0.12%
Previous 0.11%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$97.75 - $129.67 $28,347 - $37,604
-290 Reduced 14.05%
1,774 $225 Million
Q2 2024

Jul 18, 2024

BUY
$85.28 - $112.6 $176,017 - $232,406
2,064 New
2,064 $224 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $13.1B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Everpar Advisors LLC Portfolio

Follow Everpar Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everpar Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Everpar Advisors LLC with notifications on news.